FIELD: immunology and biotechnology. SUBSTANCE: majority of reconstructed antibody comes from human antibody and CDR shows low antigenicity for human body. Reconstructed antibody is encoded by DNA sequence contained in expression vector. EFFECT: enabled use in therapy because of low antigenicity. 15 cl, 8 dwg, 5 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECONSTRUCTED HUMAN ANTI-HM 1,24 ANTIBODY, DNA ENCODING H- AND L-CHAIN OF HUMAN ANTI-HM 1,24 ANTIBODY, VECTOR, METHOD OF PREPARING RECONSTRUCTED HUMAN ANTI-HM 1,24 ANTIBODY, PHARMACEUTICAL COMPOSITION FOR MYELOMA TREATMENT | 1997 |
|
RU2184147C2 |
| H- AND L-CHAINS OF MONOCLONAL ANTIBODY PM-1 (MONAT) TO HUMAN IL-6R RECEPTOR AND THEIR V-REGION, MODIFIED MONAT, ITS H- AND L-CHAINS AND THEIR V-REGIONS, CDR-SEQUENCE, DNA-SEQUENCE | 1992 |
|
RU2139351C1 |
| AGENT USED IN TREATMENT OF LYMPHATIC TISSUE TUMORS | 1998 |
|
RU2177805C2 |
| MODIFIED ANTAGONISTIC ANTIBODY | 2001 |
|
RU2295537C2 |
| AGENT FOR CARDIOPATHY | 2006 |
|
RU2450830C2 |
| DEGRADED ANTIBODY AS TPO AGONIST | 2001 |
|
RU2287534C2 |
| MONOCLONAL ANTIBODIES CAPABLE OF BINDING WITH AXL PROTEIN AND THEIR APPLICATION | 2008 |
|
RU2559530C2 |
| ANTIBODIES RAISED AGAINST PROTEIN RELATED TO HUMAN PARATHYROID HORMONE | 2002 |
|
RU2322453C2 |
| ANTI-GLYPICAN 3-ANTIBODY HAVING MODIFIED SUGAR CHAIN | 2005 |
|
RU2451030C2 |
| METHOD AND SET FOR DETECTING GENE ENCODING MEMBRANE-BOUND PROTEIN, VECTOR (VARIANTS) | 1999 |
|
RU2246538C2 |
